CANNABIS POLAND AB ZY-10 - Asset Resilience Ratio

Latest as of December 2025: 57.87%

CANNABIS POLAND AB ZY-10 (8TE) has an Asset Resilience Ratio of 57.87% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CANNABIS POLAND AB ZY-10 (8TE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€1.74 Million
≈ $2.04 Million USD Cash + Short-term Investments

Total Assets

€3.01 Million
≈ $3.52 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how CANNABIS POLAND AB ZY-10's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of CANNABIS POLAND AB ZY-10.

Liquid Assets Composition Over Time

This chart breaks down CANNABIS POLAND AB ZY-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read CANNABIS POLAND AB ZY-10 balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €1.74 Million 57.87%
Total Liquid Assets €1.74 Million 57.87%

Asset Resilience Insights

  • Very High Liquidity: CANNABIS POLAND AB ZY-10 maintains exceptional liquid asset reserves at 57.87% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

CANNABIS POLAND AB ZY-10 Industry Peers by Asset Resilience Ratio

Compare CANNABIS POLAND AB ZY-10's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for CANNABIS POLAND AB ZY-10 (2023–2025)

The table below shows the annual Asset Resilience Ratio data for CANNABIS POLAND AB ZY-10.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 57.87% €1.74 Million
≈ $2.04 Million
€3.01 Million
≈ $3.52 Million
-16.04pp
2024-12-31 73.90% €3.09 Million
≈ $3.62 Million
€4.19 Million
≈ $4.90 Million
+10.44pp
2023-12-31 63.46% €1.16 Million
≈ $1.36 Million
€1.84 Million
≈ $2.15 Million
--
pp = percentage points

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic
Market Cap
$2.06 Million
€1.76 Million EUR
Market Cap Rank
#30379 Global
#2647 in Germany
Share Price
€0.03
Change (1 day)
-1.67%
52-Week Range
€0.02 - €0.05
All Time High
€0.69
About

Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more